0

Journal Articles

in Health Promotion/Disease Prevention
 61-80 of 264 Articles
Medical News and Perspectives |  September 19, 2012
Online Programs Help With Weight Loss
Bridget M. Kuehn
JAMA. 2012;308(11):1079. doi:10.1001/2012.jama.11008.
Original Contribution |  September 19, 2012 FREE
Exercise Dose and Diabetes Risk in Overweight and Obese Children:  A Randomized Controlled Trial
Catherine L. Davis, PhD; Norman K. Pollock, PhD; Jennifer L. Waller, PhD; et al.
JAMA. 2012;308(11):1103-1112. doi:10.1001/2012.jama.10762.
Viewpoint |  September 19, 2012
Cardiovascular Risk Assessment in the Development of New Drugs for Obesity
William R. Hiatt, MD; Allison B. Goldfine, MD; Sanjay Kaul, MD
JAMA. 2012;308(11):1099-1100. doi:10.1001/jama.2012.9931.
From the Centers for Disease Control and Prevention |  September 19, 2012 FREE
Motor Vehicle Crash Deaths in Metropolitan Areas—United States, 2009
JAMA. 2012;308(11):1082-1084. doi:.
Editorial |  August 22, 2012
Cardiovascular Risk Assessment in the 21st Century
J. Michael Gaziano, MD, MPH; Peter W. F. Wilson, MD
JAMA. 2012;308(8):816-817. doi:10.1001/2012.jama.10456.
Health Agencies Update |  August 22, 2012
Smoking Cessation Reminders
Bridget M. Kuehn
JAMA. 2012;308(8):753b. doi:10.1001/2012.jama.10697.
Original Contribution |  August 22, 2012 FREE
Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals
Joseph Yeboah, MD, MS; Robyn L. McClelland, PhD; Tamar S. Polonsky, MD, MSCI; et al.
JAMA. 2012;308(8):788-795. doi:10.1001/jama.2012.9624.
INCLUDES: , Supplemental Content
Original Contribution |  August 22, 2012 FREE
Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction:  A Meta-analysis
Hester M. Den Ruijter, PhD; Sanne A. E. Peters, MSc; Todd J. Anderson, MD; et al.
JAMA. 2012;308(8):796-803. doi:10.1001/jama.2012.9630.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  August 15, 2012
Punitive Laws Undermine HIV Prevention, Says Report
Rebecca Voelker
JAMA. 2012;308(7):661. doi:10.1001/jama.2012.9970.
Health Agencies Update |  July 25, 2012
Preventing HIV Infections
Bridget M. Kuehn
JAMA. 2012;308(4):331. doi:10.1001/jama.2012.8754.
Viewpoint |  July 25, 2012
The Future of HIV Prevention in the United States
Jonathan Mermin, MD, MPH; Kevin A. Fenton, MD, PhD
JAMA. 2012;308(4):347-348. doi:10.1001/jama.2012.8693.
Editorial |  June 20, 2012
Use of Emerging Lipoprotein Risk Factors in Assessment of Cardiovascular Risk
Scott M. Grundy, MD, PhD
JAMA. 2012;307(23):2540-2542. doi:10.1001/jama.2012.6896.
Editorial |  June 06, 2012
Hemorrhagic Complications Associated With Aspirin:  An Underestimated Hazard in Clinical Practice?
Jolanta M. Siller-Matula, MD, PhD
JAMA. 2012;307(21):2318-2320. doi:10.1001/jama.2012.6152.
Medical News and Perspectives |  June 06, 2012
FDA Aims to Curb Farm Use of Antibiotics
Bridget M. Kuehn
JAMA. 2012;307(21):2244-2245. doi:10.1001/jama.2012.4560.
Viewpoint |  May 23, 2012
Assessing Value in Health Care Programs
Kevin G. Volpp, MD, PhD; George Loewenstein, PhD; David A. Asch, MD, MBA
JAMA. 2012;307(20):2153-2154. doi:10.1001/jama.2012.3619.
Viewpoint |  May 02, 2012
Choosing Wisely:  Helping Physicians and Patients Make Smart Decisions About Their Care
Christine K. Cassel, MD; James A. Guest, JD
JAMA. 2012;307(17):1801-1802. doi:10.1001/jama.2012.476.
Editorial |  April 25, 2012
Text Messaging:  A New Tool for Improving Preventive Services
Peter G. Szilagyi, MD, MPH; William G. Adams, MD
JAMA. 2012;307(16):1748-1749. doi:10.1001/jama.2012.524.
Research Letters |  April 25, 2012 FREE
2008 US Preventive Services Task Force Recommendations and Prostate Cancer Screening Rates
Sandip M. Prasad, MD, MPhil; Michael W. Drazer, BA; Dezheng Huo, MD, PhD; et al.
JAMA. 2012;307(16):1692-1694. doi:10.1001/jama.2012.534.
Capitol Health Call |  April 11, 2012
Drug Program Probed
Mike Mitka
JAMA. 2012;307(14):1476. doi:10.1001/jama.2012.416.
Viewpoint |  March 21, 2012
Evaluating Sex Differences in Medical Device Clinical Trials:  Time for Action
Sanket S. Dhruva, MD; Rita F. Redberg, MD, MSc
JAMA. 2012;307(11):1145-1146. doi:10.1001/jama.2012.254.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
Andrea Messori, PharmD; Valeria Fadda, PharmD; Dario Maratea, PharmD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Noncommunicable Diseases in Developing Countries: Focus on Research Capacity Building
Ayodele Odutayo, BHSc; Naheed Hirji, BASc
JAMA Pediatrics
Correction  |  June 01, 2013
Omission in eTable in: Prevention of Adult Obesity: How Much Weight Change Is Necessary for Normalization of Weight Status in Children?
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Rapid Assessment of Cardiovascular Risk Among Users of Smoking Cessation Drugs Within the US Food and Drug Administration's Mini-Sentinel Program
Sengwee Toh, ScD; Meghan A. Baker, MD, ScD; Jeffrey S. Brown, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems